CD8A and atherosclerosis: Depletion of CD8+ T cells with anti-CD8α or -CD8β antibodies in Apoe−/− [17] or Ldlr−/− mice [18] attenuated atherosclerosis by modulating monopoiesis in the bone marrow and reducing circulating monocyte levels in the blood.